- 2 days & nights inpatient stay
- 9 quick follow-up appointment
Participants will be reimbursed up to $1,820 for participating in this study and this clinical trial has been approved by an independent ethics committee.
About the study
Muscular dystrophy (MD) is the name given to a group of genetic conditions where a person experiences a loss of muscle mass, strength and function.
This results in reduced mobility and can be fatal in some cases. Currently there are treatments available for some MD’s, but they have problems such as significant side effects or suboptimal effectiveness. There is a need to develop new treatments for muscular dystrophies.
While most forms of MD occur in babies or children, some others appear in late adolescence or adulthood. It is estimated that there are more than 20,000 people in Australia who have some form of neuromuscular disease. Life expectancy for some MD’s can be only until early adulthood. Through early diagnosis, proper therapy and support an increased quality of life is possible.
We require healthy postmenopausal female participants who do not have the condition so we can monitor how a healthy body processes the medication. The results from this study will help determine whether the drug will progress into patient studies – giving the treatment to those who could benefit from it.
You can use your time to help with this important medical research.
How do I find out more?
If you have already registered with us but would like more information about this study, please call 1800 243 733 or schedule a call back. You can also email us at email@example.com quoting “Postmenopausal Study”.
If you are interested in participating and have not previously registered as a participant with us, fill in your details in the form below and we’ll be in touch soon!